Hypothesis

Repeated bouts of hormetic stress (e.g., exercise, fasting) followed by timed senolytic clearance convert the temporary protective pathways activated by hormesis into a cumulative reduction of senescent burden, thereby producing lasting tissue rejuvenation.

Mechanistic Rationale

• Hormetic stressors activate compensatory pathways (SIRT1, FOXO, HSPs, autophagy) but also generate new senescent cells, especially in aged tissues [4].
• Senescent cells secrete SASP factors that blunt the very stress‑response pathways hormesis relies on, creating a self‑limiting loop [4].
• Senolytics such as dasatinib + quercetin eliminate these senescent cells, rescuing the ability of hormetic stimuli to trigger adaptive signaling [4].
• If senolytics are administered after a hormetic bout, they remove the damage freshly created by that bout before SASP can accumulate and interfere with subsequent stress‑response activation.
• Over successive cycles, each hormetic episode adds a wave of transiently activated repair pathways, while the senolytic step permanently clears the senescent by‑product, allowing net damage to decline rather than remain flat.

Testable Predictions

1. Enhanced functional outcome – In aged mice, a regimen of weekly treadmill exercise followed 24 h later by dasatinib + quercetin will produce a greater increase in grip strength and endurance after 8 weeks than either exercise alone or senolytics alone.
2. Reduced senescent burden – The combined group will show a lower percentage of p16^INK4a^‑positive cells in skeletal muscle and adipose tissue compared with the exercise‑only group, despite identical exercise exposure.
3. Pathway persistence – Markers of hormetic pathway activation (e.g., nuclear FOXO3, LC3‑II) will remain elevated between sessions in the combined group, indicating that the temporary response is not fully decaying before the next hormetic stimulus.
4. Reversal by mistiming – Giving senolytics before exercise or at random intervals will abolish the synergistic benefit, yielding outcomes similar to monotherapies.
5. Dose‑response threshold – If the senolytic dose is insufficient to clear the exercise‑induced senescent wave, the benefit will plateau, demonstrating dependence on effective damage removal.

Experimental Design (Falsifiable)

• Groups (n = 10 per group, 24‑month‑old C57BL/6 mice):
  1. Sedentary + vehicle
  2. Exercise only (treadmill 30 min, 5 days/wk)
  3. Senolytics only (dasatinib 5 mg/kg + quercetin 50 mg/kg, oral, twice weekly)
  4. Exercise → senolytic (24 h post‑exercise, twice weekly)
  5. Senolytic → exercise (24 h pre‑exercise, twice weekly)
  6. Exercise + low‑dose senolytic (sub‑effective dose)
• Measurements taken at baseline, 4 wks, and 8 wks:
  • Grip strength and treadmill exhaustion time
  • Flow cytometry for p16^INK4a^ and SASP cytokines (IL‑6, MCP‑1)
  • Western blot for SIRT1, FOXO3 phosphorylation, LC3‑II
  • Histological assessment of muscle fiber cross‑sectional area
• Statistical analysis: Two‑way ANOVA with post‑hoc Tukey; significance set at p < 0.05.

Potential Falsification

If the exercise → senolytic group does not show a statistically significant improvement in functional outcomes or a reduction in senescent markers relative to exercise‑only, the hypothesis is falsified. Likewise, if pre‑exercise senolytic administration yields equal or greater benefit than post‑exercise timing, the proposed mechanistic window is incorrect.

Broader Implication

Confirming this hypothesis would reposition hormesis from a merely compensatory, temporary strategy to a priming step that, when paired with periodic damage removal, drives progressive tissue revitalization. It would also suggest that the longevity value of intermittent stressors depends critically on the clearance of the very damage they produce.